drugset / Trial / NCT01793051

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

NCT01793051

RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical research study is to learn if minocycline can help reduce the symptoms reported by patients with MM who receive therapy with lenalidomide. Minocycline is an antibiotic and has been shown to interrupt pro-inflammatory cytokine production, which may help to reduce multiple symptoms.

Timeline

Start
2013-03-22
Primary completion
2020-09-18
Completion
2020-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg Oral

Indications